Clinical trial
Registration of Children With CML and Treatment With Imatinib
NCT00445822 · Technische Universität Dresden, Other · Unknown status
Key facts
| NCT number | NCT00445822 |
|---|---|
| Title | Registration of Children With CML and Treatment With Imatinib |
| Official title | Protocol for Standardized Diagnostic Procedures, Registration, and Treatment Recommendations in Children and Adolescents With Philadelphia Chromosome-positive Chronic Myeloid Leukemia (CML) |
| Acronym | CML-paed II |
| Lead sponsor | Technische Universität Dresden, Other |
| Collaborators | Medical Academy of Wroclaw, Poland University of Leiden, Netherlands Nordic Society for Pediatric Hematology and Oncology University of Genua, Italy |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Myeloid Leukemia, Chronic |
| Enrollment | 150 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Mar 9, 2007 |
| Last update posted | Feb 29, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: